Skip to content
Sign inSign up
Revelation News
FDA Advisory Panel Endorses Grail's Galleri Blood Test for Multi-Cancer Screening
Health

FDA Advisory Panel Endorses Grail's Galleri Blood Test for Multi-Cancer Screening

Source Summary

An FDA advisory panel has endorsed Galleri, a blood test developed by biotech company Grail designed to screen for multiple types of cancer. The panel determined that the benefits of the test outweigh its risks.

Why it matters

FDA advisory panel endorsement is a significant step toward potential regulatory approval of a multi-cancer screening blood test that could expand early detection options.

Read the Source

NASDAQ:GRALLive chart